Last reviewed · How we verify

NCT06776484: WHIP

Biological Evolution of Whipple's Disease (WHIP)

Completed Last updated 15 January 2025
What this trial tests

trial in Whipple Disease in 20 participants. Completed in 31 December 2024.

Timeline
1 September 2024
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 September 2024
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Whipple Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Whipple's disease (WD), a rare systemic infection by Tropheryma whipplei, lacks research on biological abnormalities pre- and post-treatment. This study explores these abnormalities for their diagnostic and monitoring value.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06776484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing